DS
FBT icon

David Shaw’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

David Shaw’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
11,277
+5,466
+94% +$1.18M ﹤0.01% 2916
2026
Q1 		$1.17M Buy
+5,811
New +$1.2M ﹤0.01% 3336

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

David Shaw's FBT Position: Q2 2026 in Review

David Shaw increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 94% in Q2 2026, buying an estimated $1.18M and bringing the position to 11,277 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2916.

David Shaw first reported a position in FBT in Q1 2026 and has held it in 2 quarters since. 338 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • David Shaw held 11,277 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.8M as of Q2 2026.
  • David Shaw bought 5,466 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.18M.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2916 holding.
  • David Shaw first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and has held it in 2 quarters since.
  • 338 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.